BALKRISIND.NS(BALKRISIND.NS)
BALKRISIND.NS
No analyst ratings available
No analyst price targets available for BALKRISIND.NS
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $131.81B | $153.01B | $175.36B | $218.65B |
| Low | $129.57B | $144.70B | $168.84B | $210.52B |
| High | $138.49B | $167.33B | $188.33B | $234.81B |
| EBITDA Avg | $34.86B | $40.47B | $46.38B | $57.83B |
| Low | $34.27B | $38.27B | $44.65B | $55.68B |
| High | $36.63B | $44.25B | $49.81B | $62.10B |
| EBIT Avg | $26.39B | $30.64B | $35.11B | $43.78B |
| Low | $25.94B | $28.97B | $33.80B | $42.15B |
| High | $27.73B | $33.50B | $37.71B | $47.01B |
| Net Income Avg | $15.88B | $19.48B | $22.54B | — |
| Low | $14.34B | $17.55B | $21.45B | — |
| High | $18.59B | $24.43B | $24.70B | — |
| EPS Avg | $82.14 | $100.77 | $116.58 | — |
| Low | $74.17 | $90.80 | $110.94 | — |
| High | $96.13 | $126.34 | $127.78 | — |
| Analysts (Rev / EPS) | 7 / 7 | 10 / 11 | 5 / 4 | 5 / 5 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $29.20B | $33.47B | $34.75B |
| Low | $29.20B | $33.47B | $34.75B |
| High | $29.20B | $33.47B | $34.75B |
| EBITDA Avg | $7.72B | $8.85B | $9.19B |
| Low | $7.72B | $8.85B | $9.19B |
| High | $7.72B | $8.85B | $9.19B |
| EBIT Avg | $5.85B | $6.70B | $6.96B |
| Low | $5.85B | $6.70B | $6.96B |
| High | $5.85B | $6.70B | $6.96B |
| Net Income Avg | $3.39B | $3.94B | $4.82B |
| Low | $2.87B | $3.94B | $4.82B |
| High | $3.91B | $3.94B | $4.82B |
| EPS Avg | $17.54 | $20.38 | $24.91 |
| Low | $14.84 | $20.38 | $24.91 |
| High | $20.24 | $20.38 | $24.91 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 2 | 1 / 1 |